Poster Presentations - list

Poster Presentations - list

POSTER PRESENTATIONS

 

The Poster Presentation session will take place on Sat., March 4 from 15:45 till 18:00.

  • Posters are to be mounted on Fri., March 3, from 11:00 till 15:30 (preferably as early as possible).

  • Posters must be manned during the Poster Presentation Session.

    • Posters should be dismounted on Sat., March 5, after the scientific program concludes at 15:30. The organizers are not responsible for posters that are not dismounted.

 

POSTER PRESENTATION LIST

 

P-001

Microparticles cause preeclampsia and embryonic growth restriction by platelet-mediated inflammasome activation in the embryonic trophoblast

S. Kohli, M. M. Al-Dabet, S. Ranjan, F. Bock, K. Shahzad, A. Aharon, B. Brenner and B. Isermann

 

P-002

p45-NF-E2 regulates syncytiotrop formation in human placenta by modulation GCM-1 post translational modifications

S. Kohli, J. Hoffman, M. M. Al-Dabet, K. Shahzad, A. Aharon, B. Brenner and B. Isermann

 

P-003

Association between venous thromboembolism and assisted reproductive technologies: Data from the RIETE Registry

P. Di Micco, A. Blanco Molina, D. Colaizzo, A. Fontanella, M. Amitrano, F. Dentali, E. Grandone M. Monreal for the RIETE Investigators

 

P-004

Age-related risk of venous thromboembolism in women with antithrombin deficiency

A.L. Marshall, J. Perez Botero, D.J. Crusan, T.M. Petterson, J.C. Guenther3, A.V. Chintakuntlawar, R.K. Pruthi, A.A. Ashrani, MS, J.A. Heit, and M.S. Patnaik

 

P-005

Venous thromboembolism risk in pregnant women with antithrombin deficiency

A.L. Marshall, J.Perez Botero, D.J. Crusan, T.M. Petterson, J.C. Guenther, A.V. Chintakuntlawar, R.K. Pruthi, A.A. Ashrani, J.A. Heit and M.S. Patnaik

 

P-006

Composition of Soluble Fibrin Monomer Complex in Plasma of Patients with Ischemic Stroke

N. Shabanova, T. Katrii, O. Savchuk

 

P-007

Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density

P. Galambosi, V. Hiilesmaa, V.-M. Ulander, L. Laitinen, Prof A. Tiitinen, Prof R. Kaaja

 

P-008

Intra-abdominal hypertension syndrome in the genesis of the trombotic microangiopathy in pregnant women with pre-eclampsia

E.M. Shifman, D.V. Marshalov, I.A. Salov, A.P. Petrenko, A.V. Kulikov

 

P-009

Is obesity a risk factor for massive postpartum hemorrhage?

E.M. Shifman, D.V. Marshalov, I.A. Salov, A.V. Kulikov

 

P-010

Compress utilization as an objective marker to identify the fall of haemoglobin in vaginal deliveries

J. Tardif, R. Winikoff, C. Taillefer, M. David, D. Francoeur

 

P-011

TRAnexamic acid to reduce blood loss in hemorrhagic cesarean delivery: Therapeutic and pharmaco-biological dose-ranging multicenter randomized double blind placebo controlled study: TRACES trial methodology

AS. Ducloy-Bouthors, E. Jeanpierre, B. Hennart, AS. Baptiste, S. Giovannoni, I. Saidi, E. Simon, D. Lannoy, D. Allorge, A. Duhamel, S. Susen

 

P-012

Thrombin and plasmin generation as measured by a single well technique during haemorrhagic and non-hemorrhagic caesarean section: pilot study

AS. Ducloy-Bouthors, E. Jeanpierre, B. Hennart, AS. Baptiste, S. Giovannoni, I. Saidi, E. Simon, D. Lannoy, D. Allorge, A. Duhamel, S. Susen

 

P-013

Thrombin- plasmin generation in a well innovative method development: Effect of tranexamic acid concentration in vitro

AS. Ducloy-Bouthors, E. Jeanpierre, B. Hennart, AS. Baptiste, S. Giovannoni, I. Saidi, E. Simon, D. Lannoy, D. Allorge, A. Duhamel, S. Susen

 

P-014

Anything but typical: Recognising postpartum atypical haemolytic uraemic syndrome

R. Eslick, P. Motum, AM. Watson, D. Hsu

 

P-015

Association of FOXD1 variants with pregnancy failures in mice and humans

P. Laissue, B. Lakhal, M. Vatin, F. Batista, G. Burgio, E. Dos Santos, C. Buffat, AC. Sierra-Diaz, G. Renault, X. Montagutelli, J. Salmon, P. Monget, RA. Veitia, C. Méhats, M. Fellous, J. Cocquet, D. Vaiman and JC. Gris, The Collaborative Group on Precision Medicine in Pregnancy-related Diseases

 

P-016

Risk factors of stroke and venous thromboembolism in association with combined oral contraceptives use

P. Dulíček; E. Ivanová; P. Sadílek; M. Beránek

 

P-017

High prevalence of mental disorders among patients with inherited protein S deficiency: A case report series

S. Hoirisch-Clapauch, A.E. Nardi

 

P-018

Amniotic fluid embolism presenting in the second and third trimester and subsequent pregnancy outcome

T. Cahan, M.D., H. De Castro, M.D., A. Kalter, M.D., M.J. Simchen, M.D.

 

P-019

Fetal and maternal morbidity associated with late preterm delivery due to preeclampsia

B. zion Shachar, M. Zadok, S. Mazaki-Tovi, M. Simchen

 

P-020

Effects of chemotherapy administration on thrombogenicity and angiogenic properties of extracellular vesicles obtained from breast cancer patients

A. Aharon, A. Rebibo-Sabbah, G. Barsela, D. Loven, S. Nusboum, H. Berkovich, B. Brenner

 

P-021

Artemis Study: Diagnostic management of symptomatic pulmonary embolism in pregnant patients

L.M. van der Pol, T. van der Hulle, C. Tromeur, F. Couturaud, A.T.A. Mairuhu, F.A. Klok, M.V. Huisman

 

P-022

Great discrepancies in the management of placental-mediated complications and thromboprophylaxis during pregnancy in the routine clinical practice; Results from the TEAM Project

A. Santamaría, E. Marti , A. Redondo Izal, I. de Diego, A. Rodriguez Huerta, P. Llamas, J. Rodríguez-Martorell, T. Canals , O. Martínez, M. Casellas, I.M. Ramírez, M.J. Gutiérrez-Pimentel, D. Tássies on behalf of the TEAM Project (Trombosis en el Ámbito de la Mujer) Investigators of the Spanish Society of Thrombosis and Haemostasis (SETH); Spain

 

P-023

The role of Thrombophilia Tests as part of the work-up study in Women with Recurrent Pregnancy Loss (RPL)in Assisted Reproductive Technology (ART) Unit

T. Canals, J. Herrero, P. Olivera, E. Johannsson, V. Pons, F. Bosch, A. Santamaria

 

P-024

Direct oral anticoagulation (DOACs) in women with active cancer and atrial fibrillation (AF): A good example of personalised anticoagulation

A. Varela-Magallon, E. Johansson, P. Olivera, T. Canals, V. Pons, F. Bosch, A. Santamaria

 

P-025

Evaluation of haemostatic disorders in adolescent girls

V. Pons, P. Olivera, T. Canals, E. Johansson, N. Vallejos, A. Varela, M. Constans, V. Cortina, F. Bosch, A. Santamaria

 

P-026

The prevalence of concomitant prothrombotic risk factors in women with thrombosis related to hormonal treatment (HT)

M. Ramirez Isabel, M. Quesada, M. Peinado, A. Santamaría on behalf of the TEAM Project from the SETH, Spain

 

P-027

Management of pregnant patients with beta thalassemia trait

L. Bevis, E. Burton, Q. Hill, E. Ciantar

 

P-028

Audit on the management of pregnant patients with heritable thrombophilias

L. Brooke, P. Peries Suriapperuma, E. Ciantar

 

P-029

Aplastic Anaemia (AA) with paroxysmal nocturnal haemoglobinuria (PNH) complicated by severe early onset pre-eclampsia - The complexities and challenges of management

S. Kakara, E. Ciantar

 

P-030

Venous thromboembolism (VTE) in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) - underlying prothrombotic condition in active disease?

A. Antovic, E. Svensson, O. Börjesson, A. Bruchfeld, I. Gunnarsson

 

P-031

A suspected torn soleus muscle as presenting manifestation of acquired haemophilia A: a diagnostic pitfall

Y. Van der Beken, C. Orlando, K. Fostier, K. Jochmans

 

P-032

Noninvasive prenatal detection of int22h-related inversions and point mutations in maternal plasma of hemophilia carriers by single molecule counting strategies

R. Kadir, J. Davies, B. Jradeh, K. Gomez, D. Pollard, I. Hudecova, P. Jiang, R. Chiu, D. Lo

 

P-033

Use of D-Dimers in the investigation of suspected venous thromboembolism in pregnancy

E. Millen, S. Pavord

 

P-034

Multiple impedance aggregometry (Multiplate®) in healthy women during normal pregnancy – a prospective and longitudinal study

L. Blomqvist, A. Strandell, F. Baghaei, M. Hellgren

 

P-035

May-Thurner syndrome and pregnancy

A. Kovač, M. Kozak

 

P-036

Lipoprotein (A) as a risk factor for recurrent miscarriage and the effect of low-molecular-weight heparin: An analysis of the ETHIG II trial

E. Schleussner, G. Kamin, S. Seeger and D. Petroff on behalf of the ETHIGII study group

 

P-037

Progesterone supplementation for preventing recurrent miscarriage - A secondary analysis of the ETHIG II trial

G. Seliger, G. Kamin, N. Rogenhofer, S. Ebner, B. Toth, M. Schenk, M. Henes, M. K. Bohlmann, T. Fischer, D. Petroff and E. Schleussner on behalf of the ETHIGII study group

 

P-038

Women’s self-reported experience on LMWH injections for venous thromboembolism prophylaxis during port-partum

E. Le Moigne, B. Pan-Petesch, C. Tromeur, C. Tremouilhac, M. Jacquot, G. Drugmanne, S. Jolas, Z. Alavi, K. Lacut, D. Mottier

 

P-039

Evaluation of bleeding complications in postpartum women receiving therapeutic anticoagulation

G. Côté-Poirier, N. Bettache, M. Mahone, F. Morin, AM. Côté, YA. Bureau, N. Sauvé

 

P-040

Novel management of ITP resistant to IVIG and steriods

J. Byrne, V. O’Dwyer, K. Murphy

 

P-041

Long-term follow-up of laboratory markers and clinical and obstetric morbidity of women with obstetric antiphospholipid syndrome (OAPS)

C.E. Casali Congs, M. Garate Gonzalo, M. Zerga, A. Vicente Reparaz, C. Mahuad, F. Aizpurúa, M. Clavijo, A. Ventura

 

P-042

Planning the APPLE (AntiPhosPholipid syndrome Low-molecular-weight heparin pregnancy loss Evaluation) Clinical trial: An international survey of physicians

L. Skeith, T.S. Taylor, S.M. Bates, R.M. Silver, M.A. Rodger

 

P-043

Genes polymorphism FV leiden G1691A, FII G20210A, MTHFR C677T and PAI-1 5G/4G in patients with miscarriages and inherited thrombophilia - Experience from our clinic

G.M. Šošić, S. Sretenović, M. Varjačić

 

P-044

Thrombophilia: Women-specific reference ranges are needed to prevent overdiagnosis

C.S.B. Veen, M.J.H.A. Kruip, S. van Asten, W. Visser, M.P.M. de Maat

 

P-045

Dead fetus syndrome (DFS) in a high risk twin pregnancy – is laboratory testing for DIC useful?

F. Bergmann, A. Czwalinna, H. Groening, R. Schwerdtfeger, R. Schild and U. Budde

 

P-046

Circulating microparticles in pregnant patients with primary antiphospholipid antibody syndrome

E. Campello, C. M. Radu, M. Tonello, A. Kuzenko, C. Bulato, E. Mattia, L. Spiezia, A. Ruffatti, P. Simioni

 

P-047

Circulating microparticles in women with polycystic ovary syndrome: Preliminary results

E. Campello, R. Mioni, A. Dalla Cà, L. Spiezia, S. Maggiolo, C.M. Radu, C. Bulato, P. Simioni

 

P-048

Women who experience thrombosis after commencing hormone replacement therapy are not inherently prothrombotic - A case control study from the wisdom trial

C.N Bagot, E. Leishman, G.O D Lowe, M. Woodward, P. McCallum

 

P-049

Prevalence and presentation of antiphophospholipid syndrome in a tertiary obstetric unit over 11 years

WH. Tam, LW. Law, NCN. Chan

 

P-050

Safety and efficacy of LMWH in high risk pregnancy setting; A retrospective polycentric study of 818 pregnancies in Greece

E. Papadakis, Α. Aktipi, G. Αnagnostou, P. Kotsi, A. Fifa, A. Christoforidou, E. Grouzi

 

P-051

Thrombosis lymphoma score performance in female population

D. Antic, N. Milic, S. Nikolovski, M. Todorovic, J. Bila, P. Djurdjevic, B. Andjelic, V. Djurasinovic, A. Sretenovic, V. Vukovic, J. Jelicic, B. Mihaljevic

 

P-052

Mild-to-moderate bleeding tendency of unknown cause is common in women and might be caused by increased fibrinolysis

J. Gebhart, S. Kepa, S. Hofer, S. Koder, A. Kaider, A.S. Wolberg, H. Haslacher, P. Quehenberger, E. Eigenbauer, S. Panzer, C. Mannhalter, I. Pabinger

 

P-053

Establishing reference ranges for coagulation parameters during pregnancy

S. Halimeh, G. Kappert, H. Rott, M. Siebert

 

P-054

Analysis of thrombotic risk factors in caesarean sections in Vall d´Hebron population and comparison between Royal College´s recommendations and Chest´s ones

E. Bonacina, M. Casellas Caro, M.H. Tur Torres, B. Serrano Sanchez, E. Carreras Moratonas

 

P-055

Severe ITP on a term pregnancy: Case report

B. Díaz Rabasa, Laborda Gotor, MP. Rabasa Baraibar, A. Pallarés, M. Benito Vielba, JM. Campillos Maza

 

P-056

High thrombotic risk in a pregnant woman with an antithrombin deficiency; Management and outcome

A. Esteban Figuerola, A. Martínez Roca, M. Solà Fernández, A. Culebras, Mª Reyes

 

P-057

AnticoagObs: An application for antenatal and postpartum risk assessment and prophylaxis of venous thromboembolism

A.C. Lou Mercade, R. Saviron Cornudella, R. Cornudella Lacasa

 

P-058

Antiphospholipid antibodies and M2 haplotype in Annexin A5 gene: possible relationship and clinical impact on feto-maternal outcome

M. Villani, E. Chinni, G.L. Tiscia, F. Cappucci, L. Fischetti, M. Margaglione, E. Grandone

 

P-059

Venous thromboembolism in unsuccessful cycles after Assisted Reproductive Technologies (ART)

M. Villani, D. Colaizzo, F. Cappucci, P. Totaro, G. Favuzzi, M. Margaglione, E. Grandone

 

P-060

OTTILIA and FIRST: two International Registries of foeto-maternal prognosis in women with recurrent reproductive failures after spontaneous or assisted conception

M. Villani, G. Larciprete, M. Kovac, I. Martinelli, E. Tamborini Permunian, R. Cacciola, G. Lo Pinto, E. Bucherini, V. De Stefano, C. Lodigiani, T. Bartolotti, P. Totaro, D. Carone, D. Baldini, J-C. Gris, B. Brenner, M. Monreal, E. Grandone

 

P-061

Recurrent miscarriage predictive capacity using an algorithm with new genetic variants associated with thrombophilia (Thrombo inCode - recurrent miscarriage, TiC-RM)

J. Bellver, P. Alamá, V.Hugo Gómez, S. Cabanillas, C. Díaz, K. Guillén, S. Pich, I. Ortega, E. Salas

 

P-062

Recurrent implantation failure predictive capacity using an algorithm with new genetic variants associated with thrombophilia (Thrombo inCode - Implantation Failure, TiC-IF)

J. Bellver, P. Alamá, V. Hugo Gómez, S. Cabanillas, C. Díaz, K. Guillén, S. Pich, I.Ortega, E. Salas

 

P-063

Awareness of venous thromboembolism in patients with cancer: Does the gender matter?

B. Nicolau, M. García-Morillo, K. Stefi Cortes, C. Calderon, P. Gascon, C. Suarez, L. Jara Palomares, E. Colomé, J. Manzaneda, P. Fernandez-Ortega, R. Otero, M. Monreal, C. Font

 

P-064

Measures of Thrombodynamics test and fibrin monomer level in pregnant women with complicated obstetric history

J. Zvezdina; N. Vorobyeva

 

P-065

Changes in thrombin activatable fibrinolysis inhibitor (TAFI) in normal pregnancy and its role in pre-eclampsia (PET)

F.Y. Huq, R.A. Kadir, A. Riddell, B. Whitlow

 

P-066

The clinical presentations and management of Hermansky-Pudlak Syndrome (HPS) in the obstetrics and gynaecology setting - A systemic review

D. Obeng-Tuudah, K. Gomez, R. Abdul-Kadir

 

P-067

The obstetric management and outcome in carriers of haemophilia

A. Bachi, J. Davies, D. Pollard, T. Thynn Yee, R. A Kadir

 

P-068

APS and pregnancy: Is history of stillbirth associated with worse obstetric outcomes?

M. Gerde, R. Alvarez, C. Heer, J. Ortega, R. Fregonese, F. Turri, G. Di Nucci, H. Beccar Varela, J. Faisal, J. Balparda, E. Diaz Verdecchia, S. Malone, T. De Marco, S. Minces Rizo, P. Pierro, M. Iglesias, E. Beruti

 

P-069

Bernard Soulier syndrome in pregnancy and delivery – a case report

U. Scholz, M. Krause, I. Niemann, I. Bogner, A. Siegemund, K. Liebscher

 

P-070

The microparticle proteome in IVF - changes during the OESTROGEN surge of controlled ovarian hyperstimulation

N. Olausson, P. Henriksson, R. Zubarev, O. Hovatta, E. Westerlund, H. Wallen, F. Mobarrez

 

P-071

Neuraxial anesthesia in pregnant women using thrombosis prophylaxis: Data from the Highlow study

I. Bistervels, A. Buchmüller, S. Bleker, C. Chauleur, F. Ní Aínle, J. Donnelly, P. Verhamme, A. Flem Jacobsen, H. Décousus, S. Middeldorp, for the Highlow investigators

 

P-072

Bleeding and the direct oral anticoagulants (DOACS) in the < 55 year group

B. Myers, M. Willcocks

 

P-073

A case of Klippel Trenaunay syndrome (KTS) in pregnancy

B. Myers, J. Tam, F. Siddiqui

 

P-074

Perinatal venous thromboembolism state based prevention strategy: Midwifery risk assessment tool

A. Goodfellow, S. Heath, L. George, N. Muscillo, J. Curnow, J. Morris, M. Nicholl

 

P-075

Venous thromboembolism risk assessment in women is improved by the use of multilocus genetic risk scores

M. Farm, A. Ågersten, L. Onelöw, S. Pich, K. Guillen, O. Casagran, A.L. Ferro, I.Ortega, E. Salas, J. Antovic

 

P-076

A successful pregnancy in a woman with late-onset combined homocystinuria and methylmalonic aciduria

E. Grandone, G. Vecchione, G.M. Maruotti, M. Villani, A. Leccese, R. Santacroce, G. Corso, P. Martinelli, M. Margaglione

 

P-077

Risk of recurrence of venous thromboembolism in patients with gynaecological cancer

Z. Marchocki, F. Abu Saadeh, N. Gleeson, L. Norris

 

P-078

Pregnancy and venous thromboembolism: A case series analysis of clinical presentation, diagnosis, thrombophilia, treatment and outcome

M.A. Alsheef, A.M. Alabbad, R.A. Albassam, R.M. Alarfaj

 

P-079

Ovarian Vein Thrombosis Case Series Review at King Fahad Medical City in Riyadh, Saudi Arabia

M. Al Sheef, A. Altamimi, A. Alfayez, M. Alosaimi, A. Mashi

 

P-080

The clinical significance of the study of the hemostatic system in the planning of pregnancies in women taking hormonal contraceptives for a long time

N. Khamani, V. Bitsadze, D. Kapanadze

 

P-081

Pregnancy in women with history of ischemic stroke and thrombophilia

A. Makatsariya, S. Akinshina, V. Bitsadze, N. Khamani, V. Nemirovsky

 

P-082

Pregnancy after venous thromboembolic complications

S. Akinshina, V. Bitsadze, L. Radetskaya, M. Kiriya, V. Nemirovsky, A. Makatsariya

 

P-083

Catastrophic Antiphospholipid syndrome and pregnancy - A clinical case

D. Khizroeva, V. Bitsadze, A. Makatsariya

 

P-084

Antiphospholipid antibodies in women with history of severe preeclampsia

D. Khizroeva, N. Stuleva, I. Khamani, N. Zakharova, E. Zhuravleva

 

P-085

Clinical value of antiphospholipid antibodies assessment in women undergoing IVF with history of IVF failure

D. Khizroeva, N. Stuleva, N. Makatsariya, N. Khamani

 

P-086

Personalized antithrombotic prophylaxis in patients with homozygous forms of factor V leiden and prothrombin G20210A mutations and multigenic and combined form of thrombophilia and/or aps

A. Makatsariya, V. Bitsadze, N. Stuleva, D. Khizroeva, I. Khamani

 

P-087

Fetal loss syndrome, genetic hypofibrinolysis and pro-inflammatory status in women with metabolic syndrome

T. Pshenichnikova, E. Perederyaeva, V. Bitsadze, A. Makatsariya

 

P-088

The clinical significance of determining the activity and inhibitor of ADAMTS-13 in the management of pregnant women with severe preeclampsia and thrombotic microangiopathy history

A. Makatsariya, V. Bitsadze, D. Khizroeva

 

P-089

LMWH and micronized progesterone in prophylaxis pre-eclampsia in patients with thrombophilia and pre-eclampsia in anamnesis

E.V. Zhuravleva, V.O. Bitsadze, A.D. Makatsariya

 

P-090

Influence of genetic polymorphism on antithrombin III while taking combined oral contraceptives

N.A. Vorobyeva, D.R.Gamyrkina

 

P-091

The use of intravenous immunoglobulin in apa-positive women undergoing in vitro fertilization

M.I. Krivonos, M.S. Zainulina, S.V. Chepanov, D.I. Sokolov, S.A. Selkov

P-092

Immunomodulatory effect of intravenous immunoglobin in women with Antiphospholipid syndrome and recurrent miscarriage

A.A. Chugunova, M.S. Zainulina, S.A. Selkov, S.V. Chepanov, A.V. Selutin, M.I. Krivonos

P-093

3 cases of heparin-resistant deep vein thrombosis (DVT) during pregnancy due to hereditary antithrombin (AT) deficiency

T. Kirsanova, M. Vinogradova, N. Klimenchenko

 

P-094

Pregnancy-associated atypical hemolytic uremic syndrome (P-AHUS): Our experience

T. Kirsanova, M. Vinogradova

 

P-095

Laboratory features of Hellp and pregnancy-associated atypical hemolytic uremic syndrome (P-AHUS): HELLP- A link to aHUs

T. Kirsanova, M. Vinogradova

 

P-096

Pregnancy-associated thrombotic microangiopathies (Pa-TMA): features of intrarenal blood flow (IBF) in severe preeclampsia (PE), HELLP-syndrome and pregnancy-associated atypical hemolytic uremic syndrome (P-AHUS)

T. Kirsanova, M. Vinogradova

 

P-097

HELLP-Syndrome and severe preeclampsia (PE): Clinical and laboratory features

T. Kirsanova, M. Vinogradova, A. Koluvanova, T. Fedorova

 

P-098

LMWH as drugs of choice as anticoagulant therapy in cancer patients

A.V. Vorobev, I.V. Khamani, A.G. Solopova

 

P-099

Rare localizations thrombosis in cancer patients

A.V. Vorobev, A.D. Makatsaria, d.K. Khizroeva, V.O. Bitsadze

 

P-100

Clinical importance of vascular wall antithrombotic activity disorder detection in the course of hormonal replacement therapy (HRT) and its pharmacological correction

S. Ermoshina, N. Khamani, V. Bitsadze